Stokes Family Office, LLC Amgen Inc Transaction History

Stokes Family Office, LLC

$834 Million
Q2 2024

A detailed history of Stokes Family Office, LLC transactions in Amgen Inc stock. As of the latest transaction made, Stokes Family Office, LLC holds 1,911 shares of AMGN stock, worth $602,996. This represents 0.07% of its overall portfolio holdings.

Number of Shares

1,911

Previous 1,775 7.66%

Holding current value

$602,996

Previous $504,000 18.45%

% of portfolio

0.07%

Previous 0.06%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 05, 2024	BUY	$262.75 - $319.31 $35,734 - $43,426	136 Added 7.66%	1,911 $597,000
Q1 2024 May 06, 2024	BUY	$268.87 - $324.56 $11,830 - $14,280	44 Added 2.54%	1,775 $504,000
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $1.33 Million - $1.51 Million	-5,219 Reduced 75.09%	1,731 $498,000
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $294,084 - $365,113	1,345 Added 24.0%	6,950 $1.87 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $155,560 - $183,946	-726 Reduced 11.47%	5,605 $1.24 Million
Q1 2023 May 08, 2023	SELL	$225.79 - $275.2 $259,206 - $315,929	-1,148 Reduced 15.35%	6,331 $1.53 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $262,926 - $334,079	1,148 Added 18.13%	7,479 $1.96 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $1,346 - $1,518	-6 Reduced 0.09%	6,331 $1.43 Million
Q2 2022 Aug 05, 2022	BUY	$230.71 - $256.74 $134,503 - $149,679	583 Added 10.13%	6,337 $1.54 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $426,699 - $472,041	1,946 Added 51.1%	5,754 $1.39 Million
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $305,081 - $349,138	1,534 Added 67.46%	3,808 $857,000
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $24,623 - $28,849	116 Added 5.38%	2,274 $484,000
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $10,043 - $11,143	43 Added 2.03%	2,158 $526,000
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $7,988 - $9,309	36 Added 1.73%	2,115 $551,000
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $14,497 - $17,263	-67 Reduced 3.12%	2,079 $478,000
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $128,118 - $142,478	-546 Reduced 20.28%	2,146 $545,000
Q2 2020 Aug 11, 2020	BUY	$197.81 - $242.74 $25,319 - $31,070	128 Added 4.99%	2,692 $635,000
Q1 2020 May 12, 2020	BUY	$182.24 - $241.7 $150,894 - $200,127	828 Added 47.7%	2,564 $520,000
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $328,468 - $422,195	1,736 New	1,736 $419,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stokes Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stokes Family Office, LLC with notifications on news.

Account

Stokes Family Office, LLC Amgen Inc Transaction History